Hereditary hemorrhagic telangiectasia, idiopathic thrombocytopenic purpura, and chronic lymphocytic leukemia treated with rituximab [4]

American Journal of Medicine

Volumn 113, Issue 8, 2002, Pages 700-701

  Choueiri, Toni ^a   Lichtin, Alan E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; RHESUS D ANTIBODY; RITUXIMAB; STEROID; VINCRISTINE;

AGED; ANAMNESIS; ANEMIA; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; EPISTASIS; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LABORATORY TEST; LETTER; LYMPHOCYTOSIS; PRIORITY JOURNAL; REMISSION; RENDU OSLER WEBER DISEASE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0036908595     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01273-1     Document Type: Letter

References (8)

1. Duhrsen U., Augner W., Swingers T., et al. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders analysis of 637 cases and comparison with myleproliferative diseases. Br J Haematol. 67:1987;235-239.
2. Haubenstock A., Zalusky R. Autoimmune hyperthyroidism and thrombocytopenia developing in a patient with chronic lymphocytic leukemia. Am J Hematol. 19:1985;281-283.
3. George J.N., El-Harake M.A., Aster R.H. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. Beutler E., Lichtman M., Coller B.C., et al. Williams Hematology. Vol 5:1995;1315-1355 McGraw-Hill, New York.
4. O'Brien S.M., Kantarjian H., Thomas D.A., et al. Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol. 19:2001;2165-2170.
5. Nguyen D.T., Amess J.A., Doughty H., et al. IDEC-C2B8 anti-CD 20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders evaluation of response on 48 patients. Eur J Haematol. 62:1999;76-82.
6. George J.N., Koujouri K., Perdue J.J., Vesely S.K. Management of patients with chronic refractory idiopathic thrombocytopenic purpura. Semin Hematol. 37:2000;290-298.
7. Perotta A., Sunneberg T., Scott J., et al. Rituxan in the treatment of chronic idiopathic thrombocytopenic purpura (ITP). Blood. 94:1999;14.
8. Stasi R., Pagano A., Stipa E., Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood. 98:2001;952-957.